Microbiome research is a growing driver of innovation in healthcare, biotechnology, food systems, and sustainable bio-industries. However, its progress is limited by the lack of reliable and scalable in vitro tools capable of reproducing the complex environments in which many microorganisms naturally live. This challenge is particularly relevant for mucus-associated ecosystems in the human body, where many microorganisms remain difficult or impossible to culture using conventional laboratory methods.
The Bac3Gel project addressed this gap by developing and validating three-dimensional in vitro substrates that mimic key features of human mucus. By recreating native gradients of oxygen, nutrients, hydration, and mechanical properties, the Bac3Gel platform enables the stable growth of complex microbial communities under conditions that better reflect those found in vivo, allowing more physiologically relevant and reproducible microbiome studies.
The main objective of the project was to translate this mucus-mimicking technology from a laboratory-validated concept into market-ready products suitable for industrial and applied research. Through extensive technical validation in real-world research environments, the project demonstrated the robustness, scalability, and usability of the Bac3Gel platform.
By providing a ready-to-use in vitro solution, the project supports the adoption of non-animal testing methodologies, improves the predictive value of microbiome research, and accelerates the translation of microbiome science into industrial, regulatory, and healthcare applications. The outcomes benefit academic laboratories, contract research organisations, biotech SMEs, and industrial R&D teams, while contributing to European priorities on New Approach Methodologies, reduction of animal experimentation, and strengthened innovation capacity in biotechnology.
